0 Yorumlar
0 hisse senetleri
250 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Beyond Blood Sugar: SGLT2 Inhibitors and Their Cardiorenal Protective Effects in Diabetes ManagementFor individuals with Type 1 Diabetes and advanced Type 2 Diabetes, the foundation of treatment remains insulin, but the quality of life is being dramatically improved by new insulin analogues and novel delivery methods. The goal is to more closely mimic the body's natural physiological insulin response. Ultra-long-acting insulin analogues, such as insulin icodec, are being developed to allow...0 Yorumlar 0 hisse senetleri 631 Views 0 önizleme
-
The GLP-1 Revolution: Highlighting the Impact of Incretin-Based Therapies on Metabolic HealthThe introduction of drugs acting on the Glucagon-Like Peptide-1 (GLP-1) pathway has fundamentally reshaped the landscape of the endocrinology therapeutic domain over the last decade. GLP-1 receptor agonists, such as Semaglutide and Dulaglutide, mimic the action of natural incretin hormones, stimulating insulin secretion, inhibiting glucagon release, and, crucially, slowing gastric emptying....0 Yorumlar 0 hisse senetleri 670 Views 0 önizleme
-
Thyroid Function Test Market to Reach USD 3.10 Billion by 2033, Growing at a CAGR of 5.9% (2025–2033)Market Overview The global thyroid function test market size was valued at USD 1.85 billion in 2024 and is projected to grow from USD 1.96 billion in 2025 to USD 3.10 billion by 2033, growing at a CAGR of 5.90% during the forecast period (2025-2033). The global Thyroid Function Test market continues to evolve rapidly, driven by shifting consumer...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme